Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
04/2010
04/15/2010US20100093733 Amide and urea derivatives for the treatment of metabolic diseases
04/15/2010US20100093693 Modulators of cellular adhesion
04/14/2010EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof
04/14/2010EP1477482B1 Novel phenylalanine derivative
04/14/2010EP1335901B1 Pharmaceutically active sulfanilide derivatives
04/13/2010US7696242 inhibitors of the hepatitis C virus NS3 protease; azalactone intermediate reacted with cycloalkylsulfonamide and decylization; urea or carbamate-terminated alkylglycine, hydroxyproline, cyclopropylglycine tripeptide
04/13/2010CA2510773C Crystalline form of quinapril hydrochloride and process for preparing the same
04/08/2010WO2010039534A2 Viral and fungal inhibitors
04/08/2010WO2010039079A1 Isoquinolinone derivatives
04/08/2010WO2010038465A1 8-substituted isoquinoline derivative and use thereof
04/08/2010WO2009156092A3 Bi-and polycyclic substituted isoquinoline and isoquinoline derivatives as rho kinase inhibitors
04/08/2010CA2738563A1 8-substituted isoquinoline derivatives and the use thereof
04/08/2010CA2738313A1 Viral and fungal inhibitors
04/08/2010CA2737434A1 Isoquinolinone derivatives
04/07/2010EP2170826A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
04/06/2010US7691879 Isoquinoline potassium channel inhibitors
04/01/2010WO2010037050A2 Synthesis of functionalized octahydro-isoquinolin-1-one-8-carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
04/01/2010US20100081687 Biarylcarboxyarylamides as vanilloid-1 receptor modulators
04/01/2010US20100081686 Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter
04/01/2010US20100081671 Cycloalkylamine substituted isoquinoline derivatives
04/01/2010US20100080772 Hepatitis C Virus Inhibitors
03/2010
03/31/2010EP1807393B1 Diarylsulfones as 5-ht2a antagonists
03/31/2010CN101687792A Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
03/30/2010US7687504 1-[3-[2-[2-cyano-(S)-pyrrolidin-1-yl]-2-oxo-ethylamino]-1-oxo-propyl]-4-[bis-(4-fluorophenyl)methyl]piperazine; inhibiting dipeptidyl peptidase IV or for treating Type II diabetes
03/30/2010CA2389306C Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
03/25/2010US20100076016 Isoquinolinone derivatives as nk3 antagonists
03/25/2010US20100076015 Aminopyridine Derivatives
03/25/2010US20100075986 Oxophenyl-Cyclohexyl-Propanolamine Derivatives, Production And Use Thereof In Therapeutics
03/24/2010EP2166003A1 Excitatory amino acid receptor antagonists
03/24/2010EP2165709A2 Lysine based compounds
03/24/2010EP2164825A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
03/24/2010CN101679277A Novel peptide inhibitors of hepatitis c virus replication
03/24/2010CN101679276A Isoquinolinone derivatives as nk3 antagonists
03/24/2010CN101679275A New compounds 707 and their uses
03/24/2010CN101679274A phthalazine and isoquinoline derivatives with slp receptor modulating activities
03/24/2010CN101679273A 1-substituted tetrahydroisoquinoline compound
03/24/2010CN101679191A Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
03/24/2010CN100595195C Preparation method and application of isoquinoline componds and salts thereof
03/23/2010US7683073 Isoquinoline-1,3,4-trione compounds, the synthetic method and the use thereof
03/23/2010US7683064 Inhibitors of Bruton's tyrosine kinase
03/18/2010WO2010030722A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
03/18/2010WO2010028655A1 Isoquinolinone derivatives as nk3 antagonists
03/18/2010US20100069432 Bis-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors
03/18/2010US20100069405 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
03/18/2010US20100068150 Selective Caspase Inhibitors
03/18/2010CA2732612A1 Isoquinolinone derivatives as nk3 antagonists
03/17/2010EP1284966B1 Process for the synthesis of amine ethers from secondary amino oxides
03/17/2010CN101671301A Heterocyclic substituent acardite derivate and application thereof
03/16/2010US7678831 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis
03/16/2010US7678813 8a-Benzyl-2-(4-methoxyphenyl)-1,3,4,7,8,8a-hexahydro-2H-isoquinolin-6-one; psychotic major depression, schizoaffective disorder, Alzheimer's Disease and cocaine addiction
03/16/2010US7678812 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
03/16/2010US7678811 An urea compounds containing a pyridine, quinoline, or isoquinoline functionality; p38 mediated diseases such as inflammation and VEGF mediated diseases such as angogenesis disorders
03/11/2010WO2010028004A2 Substituted berbines and processes for their synthesis
03/11/2010WO2010027889A2 Process for synthesizing substituted isoquinolines
03/11/2010WO2009156099A8 6-substituted isoquinolines and isoquinolinones
03/11/2010US20100063290 Preparation of 3,4-Dihydroisoquinolines from an Acid and an Amine
03/11/2010US20100061928 Labelled analogues of halobenzamides as radiopharmaceuticals
03/11/2010CA2733533A1 Hedgehog pathway modulators
03/10/2010EP2161253A2 Process for the preparation of 3,4-dihydroisoquinolines in the synthesis of morphinans
03/10/2010CN101668747A Tetrahydroisoquinolin-1-one derivative or salt thereof
03/10/2010CN101668746A Tetrahydroisoquinoline compounds as modulators of the histamine h3 receptor
03/10/2010CN101665460A New structural compound neoliensinine and isolation and identification method thereof
03/09/2010US7674809 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
03/09/2010US7674805 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
03/09/2010CA2421819C Isoquinolinone potassium channel inhibitors
03/09/2010CA2336702C Sulfonylaminocarboxylic acid n-arylamides as guanylate cyclase activators
03/04/2010WO2010023445A1 Novel potassium channel blocker
03/04/2010US20100056792 Process for Synthesizing Substituted Isoquinolines
03/04/2010US20100056789 Substituted Berbines and Processes for their Synthesis
03/04/2010US20100056568 Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives
03/04/2010US20100056553 Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives
03/04/2010US20100056535 Inhibitors of HIV-1 reverse transcriptase
03/04/2010US20100056518 Cycloalkylamine substituted isoquinolone derivatives
03/04/2010US20100051509 Halogen-free ionic liquids in naphtha desulfurization and their recovery
03/04/2010DE102008044714A1 Kationische Dihydroisochinolinium-Derivate als Bleichaktivatoren Cationic dihydroisoquinolinium derivatives as bleach activators
03/03/2010EP2159216A1 Ih - Modulators
03/03/2010CN101663278A Compounds and compositions as modulators of GPR119 activity
03/02/2010US7671205 6-aminoisoquinoline compounds
02/2010
02/25/2010WO2010021878A1 Cold menthol receptor antagonists
02/25/2010US20100048906 Preparation of Substituted Morphinan-6-Ones and Salts and Intermediates Thereof
02/25/2010US20100048893 Substituted arylalkanoic acid derivatives and use thereof
02/25/2010US20100048619 Cold Menthol Receptor Antagonists
02/25/2010US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
02/25/2010US20100048549 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4
02/24/2010EP2155684A1 Process for producing cisatracurium compounds and associated intermediates
02/24/2010EP2155675A1 Kinase inhibitors, compositions thereof, and methods of use therewith
02/24/2010EP2155643A1 Ire-1a inhibitors
02/24/2010EP1000999B1 Compounds for organic el devices and organic el devices
02/18/2010WO2010018874A1 Amide compound
02/18/2010US20100041645 Rho kinase inhibitors
02/18/2010US20100041590 Compounds
02/18/2010US20100040545 Radiolabelling methods
02/17/2010CN100590118C Novel style heterocyclic compound as insulin-like growth factors first type acceptor inhibitor
02/16/2010US7662821 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
02/16/2010US7662816 Cognition activators; neurodegenerative disorders; Alzheimer's disease
02/16/2010CA2571627C Substituted aryl-amine derivatives and methods of use
02/16/2010CA2445329C 20-hydroxyeicosatetraenoic acid production inhibitors
02/16/2010CA2442882C Sulphones which modulate the action of gamma-secretase
02/16/2010CA2407043C Naphthamidine urokinase inhibitors
02/16/2010CA2385081C Carboxylic acid compound and a medicament comprising it
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 119